Skip links

Talent Imperatives for a Digital World

Jump To Section

2018 – this year the century turns adult. We have reached a time when the dynamics of the world’s decision makers, influencers, and consumers are set to change entirely, driven by the millennial mindset.

2018 – this year the century turns adult. We have reached a time when the dynamics of the world’s decision makers, influencers, and consumers are set to change entirely, driven by the millennial mindset.

I have seen the software industry for over 4 decades. And I believe that there hasn’t been a more dynamic and exciting time to be in, than now. The connected era changes everything. On the one hand, we can see technology fundamentally impacting business models, productivity, investments and disrupting the way businesses engage and transact with their consumers. On the other hand, new-age consumers are driven by rapidly evolving expectations, an increasing desire for personalization and demand for speed.

This pressing need for speed and agility is pushing enterprises to look at newer and alternate business models.

In the last twenty years

Globalization and the changing consumer environment compelled enterprises to invest heavily on infrastructure to become more adaptable and conducive for global expansions.

While it did make enterprises global, there remained a big challenge with siloes and gaps in capabilities. Acquisitions and outsourcing models that emerged as an impact of this global transition helped reduce IT costs and increase ROI, but they did little to address the capability gap within organizations.

In this process, technology talent also became siloed, and more focused on project and cost metrics than exploring newer ways that could differentiate business.

Digital Transformation: The Shift to Cloud and Innovation

This game-changer hit us like a digital tsunami displacing traditional giants with new digital innovators. The advent of new technologies, new business models and ecosystems, have compelled legacy organizations to experiment outside their comfort zone.

Enterprises today are looking to create a front-end digital platform that leverages existing systems, and brings speed, scale and flexibility to the business operations, leveraging a combination of the most advanced technologies. As companies focus on cost reduction, resource optimization and launching, as well as scaling up products and offerings in an agile environment, they are rapidly moving from existing infrastructure to the cloud.

Digital-Ready Talent: Key to Enduring Transformation

A strong digital front-end platform not only brings in automation, it also ushers a new talent and culture in the company that is digital-ready. I strongly believe that enterprises that create a difference in the future are not only focused on new technologies, but on how they assess and transform talent within or coming into their organization.

Increasingly, enterprises that are looking to transform themselves will seek consultative strategy not just in technology transformation but in the area of transformation that will be truly seminal – Talent & People. Hiring great talent and creating a culture that fosters it – this could be the ultimate key to the most enduring transformation of contemporary organizations who are on the firm path to be future-ready.

This article also appeared on TechStory.

Find this opinion interesting? Connect and follow Raj Vattikuti on LinkedIN to get more such insights.

Raj Vattikuti

Raj Vattikuti

Raj Vattikuti is an American-Indian entrepreneur, business executive and philanthropist. He is the Founder and Chairman of Altimetrik Corp. He is also the founder of Vattikuti Foundation. through which he is involved in many charitable causes.

Latest Reads

Subscribe

Suggested Reading

Ready to Unlock Yours Enterprise's Full Potential?

Adaptive Clinical Trial Designs: Modify trials based on interim results for faster identification of effective drugs.Identify effective drugs faster with data analytics and machine learning algorithms to analyze interim trial results and modify.
Real-World Evidence (RWE) Integration: Supplement trial data with real-world insights for drug effectiveness and safety.Supplement trial data with real-world insights for drug effectiveness and safety.
Biomarker Identification and Validation: Validate biomarkers predicting treatment response for targeted therapies.Utilize bioinformatics and computational biology to validate biomarkers predicting treatment response for targeted therapies.
Collaborative Clinical Research Networks: Establish networks for better patient recruitment and data sharing.Leverage cloud-based platforms and collaborative software to establish networks for better patient recruitment and data sharing.
Master Protocols and Basket Trials: Evaluate multiple drugs in one trial for efficient drug development.Implement electronic data capture systems and digital platforms to efficiently manage and evaluate multiple drugs or drug combinations within a single trial, enabling more streamlined drug development
Remote and Decentralized Trials: Embrace virtual trials for broader patient participation.Embrace telemedicine, virtual monitoring, and digital health tools to conduct remote and decentralized trials, allowing patients to participate from home and reducing the need for frequent in-person visits
Patient-Centric Trials: Design trials with patient needs in mind for better recruitment and retention.Develop patient-centric mobile apps and web portals that provide trial information, virtual support groups, and patient-reported outcome tracking to enhance patient engagement, recruitment, and retention
Regulatory Engagement and Expedited Review Pathways: Engage regulators early for faster approvals.Utilize digital communication tools to engage regulatory agencies early in the drug development process, enabling faster feedback and exploration of expedited review pathways for accelerated approvals
Companion Diagnostics Development: Develop diagnostics for targeted recruitment and personalized treatment.Implement bioinformatics and genomics technologies to develop companion diagnostics that can identify patient subpopulations likely to benefit from the drug, aiding in targeted recruitment and personalized treatment
Data Standardization and Interoperability: Ensure seamless data exchange among research sites.Utilize interoperable electronic health record systems and health data standards to ensure seamless data exchange among different research sites, promoting efficient data aggregation and analysis
Use of AI and Predictive Analytics: Apply AI for drug candidate identification and data analysis.Leverage AI algorithms and predictive analytics to analyze large datasets, identify potential drug candidates, optimize trial designs, and predict treatment outcomes, accelerating the drug development process
R&D Investments: Improve the drug or expand indicationsUtilize computational modelling and simulation techniques to accelerate drug discovery and optimize drug development processes